发明授权
US09193719B2 1,2,4-triazol-5-ones and analogs exhibiting anti-cancer and anti-proliferative activities
有权
1,2,4-三唑-5-酮和具有抗癌和抗增殖活性的类似物
- 专利标题: 1,2,4-triazol-5-ones and analogs exhibiting anti-cancer and anti-proliferative activities
- 专利标题(中): 1,2,4-三唑-5-酮和具有抗癌和抗增殖活性的类似物
-
申请号: US14214160申请日: 2014-03-14
-
公开(公告)号: US09193719B2公开(公告)日: 2015-11-24
- 发明人: Daniel L. Flynn , Gary E. L. Brandt , Michael D. Kaufman , Hanumaiah Telikepalli , Timothy Malcolm Caldwell , Thiwanka Samarakoon
- 申请人: Deciphera Pharmaceuticals, LLC
- 申请人地址: US KS Lawrence
- 专利权人: Deciphera Pharmaceuticals, LLC
- 当前专利权人: Deciphera Pharmaceuticals, LLC
- 当前专利权人地址: US KS Lawrence
- 代理机构: Cooley LLP
- 主分类号: A61K31/506
- IPC分类号: A61K31/506 ; C07D417/14 ; C07D401/14 ; C07D405/14 ; C07D413/14 ; A61K31/444
摘要:
Described are compounds of Formula I which find utility in the treatment of cancer, autoimmune diseases and metabolic bone disorders through inhibition of c-FMS (CSF-1R), c-KIT, and/or PDGFR kinases. These compounds also find utility in the treatment of other mammalian diseases mediated by c-FMS, c-KIT, or PDGFR kinases.
公开/授权文献
信息查询
IPC分类: